Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients.
De Sanctis V, Musio D, De Felice F, Marampon F, Valeriani M, Bonome P, Anzellini D, Facondo G, Vullo G, Massaro M, Di Staso M, Bonfili P, Chalaszczyk A, Gravina GL, Tombolini V, Osti MF. De Sanctis V, et al. Among authors: facondo g. J Contemp Brachytherapy. 2020 Apr;12(2):124-130. doi: 10.5114/jcb.2020.94581. Epub 2020 Apr 30. J Contemp Brachytherapy. 2020. PMID: 32395136 Free PMC article.
High precision radiotherapy including intensity-modulated radiation therapy and pulsed-dose-rate brachytherapy for cervical cancer: a retrospective monoinstitutional study.
Vavassori A, Riva G, Spoto R, Lazzari R, Fodor C, Dicuonzo S, Francia CM, Augugliaro M, Facondo G, Cambria R, Comi S, Cattani F, Botta F, Bagnardi V, Rizzo S, Colombo N, Orecchia R, Jereczek-Fossa BA. Vavassori A, et al. Among authors: facondo g. J Contemp Brachytherapy. 2019 Dec;11(6):516-526. doi: 10.5114/jcb.2019.90478. Epub 2019 Dec 8. J Contemp Brachytherapy. 2019. PMID: 31969909 Free PMC article.
Residual Site Radiotherapy After Immunochemotherapy in Primary Mediastinal B-Cell Lymphoma: A Monoinstitutional Retrospective Study.
DE Sanctis V, DI Rocco A, Cox MC, Valeriani M, Congedi FP, Anzellini D, Massaro M, Vullo G, Facondo G, DE Giacomo F, Alfò M, Prosperi D, Pizzichini P, Pelliccia S, Tafuri A, Martelli M, Osti MF. DE Sanctis V, et al. Among authors: facondo g. In Vivo. 2020 May-Jun;34(3):1407-1413. doi: 10.21873/invivo.11921. In Vivo. 2020. PMID: 32354938 Free PMC article.
Markers of Cardiotoxicity in Early Breast Cancer Patients Treated With a Hypofractionated Schedule: A Prospective Study.
De Sanctis V, Alfò M, Vitiello C, Vullo G, Facondo G, Marinelli L, Burocchi S, Gallo G, Valeriani M, Campanella B, Scalabrino G, Russo I, Salerno G, Cardelli P, Osti MF, De Biase L. De Sanctis V, et al. Among authors: facondo g. Clin Breast Cancer. 2021 Jun;21(3):e141-e149. doi: 10.1016/j.clbc.2020.09.005. Epub 2020 Sep 10. Clin Breast Cancer. 2021. PMID: 33012660
Stereotactic and Hypofractionated Radiotherapy Associated With Immune Checkpoint Inhibitor Drugs: Analysis of Local Control, Toxicity, and Outcome in a Single Research Centre Case Study.
Anzellini D, DE Sanctis V, Valeriani M, Reverberi C, Marinelli L, Massaro M, Vullo G, Facondo G, Sigillo RC, Tosi E, Osti MF. Anzellini D, et al. Among authors: facondo g. Anticancer Res. 2021 Oct;41(10):5107-5116. doi: 10.21873/anticanres.15327. Anticancer Res. 2021. PMID: 34593461 Clinical Trial.
Hypofractionated Radiation Therapy (HFRT) of Breast/Chest Wall and Regional Nodes in Locally Advanced Breast Cancer: Toxicity Profile and Survival Outcomes in Retrospective Monoistitutional Study.
De Matteis S, Facondo G, Valeriani M, Vullo G, De Sanctis V, Ascolese AM, Campanella B, Scalabrino G, Osti MF. De Matteis S, et al. Among authors: facondo g. Clin Breast Cancer. 2022 Apr;22(3):e332-e340. doi: 10.1016/j.clbc.2021.09.008. Epub 2021 Sep 25. Clin Breast Cancer. 2022. PMID: 34670727 Free article.
18 results